SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)
Ministry of Defence · Awarded
- Buyer
- Ministry of Defence
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-034881
- Published
- 2022-06-20
- Deadline
- 2026-05-02
Tender summary
The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), intends to place a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 10 years (5 + 5 Option Years) with an estimated value of £20m. This is necessary to ensure maintenance of the capability with an acceptable stockholding level.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access